Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,242,448
-$141,831 QoQ
Shares Held
20,642
-6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#1,585
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sepio Capital, LP holds $43,754,387 across 7 Drug Manufacturers - General names. JNJ ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
130,177 | $32,757,740 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
20,642 | $5,242,448 | |
| 3 | NVS |
Novartis AG
|
13,731 | $2,151,922 | |
| 4 | NVO |
Novo Nordisk A S
|
36,095 | $1,730,394 | |
| 5 | LLY |
ELI LILLY & Co
|
826 | $990,729 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,766 | $483,931 | |
| 7 | PFE |
Pfizer Inc
|
16,496 | $397,223 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,242,448 | 20,642 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,384,279 | 22,027 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,773,922 | 23,068 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,286,168 | 23,116 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,147,108 | 20,603 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,418,625 | 20,614 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,443,836 | 23,813 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,061,223 | 25,060 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,830,122 | 26,205 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,643,034 | 29,351 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,731,510 | 30,187 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,632,231 | 36,162 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,814,789 | 41,172 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,570,915 | 42,393 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $7,676,325 | 43,455 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $7,423,078 | 45,440 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $8,272,498 | 46,603 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $8,415,589 | 47,484 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $8,117,784 | 47,453 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $7,340,336 | 45,451 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $7,177,886 | 43,571 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,822,895 | 47,599 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,369,460 | 59,534 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,305,148 | 62,501 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,851,774 | 48,722 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $6,487,787 | 49,476 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||